Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Obstet Gynecol. 2013 Nov 4;210(1):47.e1–47.e7. doi: 10.1016/j.ajog.2013.09.039

Table 3. Specified impurity analysis of compounded 17-hydroxyprogesterone caproate (17-OHPC).

No. Conc. of CA
(μg/mL)
CA/17-OHPC
ratio (%)
Conc. of 17-OHP
(μg/mL)
17-OHP/17-OHPC
ratio (%)
1 30 0.012 242 0.10
2 0 0 99.8 0.04
3 0 0 99.0 0.04
4 0 0 107 0.04
5 30 0.012 179 0.07
6 0 0 49.5 0.02
7 0 0 52.0 0.02
8 50 0.020 53.2 0.02
9 0 0 0 0
10 0 0 0 0
11 30 0.012 47.3 0.02
12 0 0 96.2 0.04
13 0 0 152 0.06
14 0 0 51.9 0.02
15 0 0 52.4 0.02
16 0 0 48.4 0.02
17 0 0 0 0
18 0 0 0 0
Mean ± SD 7.8 ± 15.6 0.003 ± 0.006 73.8 ± 65.9 0.03 ± 0.03
90%CI 1.4 – 14.2 0.001 – 0.005 46.8 – 101 0.02 – 0.04

CA= caproic acid, 17-OHP= 17 hydroxyprogesterone

Caproic acid (CA) measured at 208 nm and 17-OHP measured at 242 nm using standard curves generated with corresponding standards.